These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7657520)

  • 1. Correlation of differences in modulation of ras expression with metastatic competence of mouse mammary tumor subpopulations.
    Shekhar PV; Miller FR
    Invasion Metastasis; 1994-1995; 14(1-6):27-37. PubMed ID: 7657520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of first exon/intron sequences in the regulation of myc family oncogenic potency.
    Xu L; Wallen R; Patel V; DePinho RA
    Oncogene; 1993 Sep; 8(9):2547-53. PubMed ID: 8361763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
    Muschel RJ
    Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
    Schlatter B; Waghorne CG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of the first intron of c-H-ras in gene expression: anti-cancer elements in oncogenes.
    Hashimoto-Gotoh T; Kikuno R; Takahashi M; Honkawa H
    Anticancer Res; 1988; 8(5A):851-9. PubMed ID: 3052257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
    Shekhar PV; Werdell J; Christman JK; Miller FR
    Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory elements in the first intron of the mouse Ha-ras gene.
    Telliez JB; Plumb M; Balmain A; Bailleul B
    Mol Carcinog; 1995 Mar; 12(3):137-45. PubMed ID: 7893367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE; Koester SK; Troyer DA; Hilsenbeck SG; Barrington RE; Windle JJ
    Cancer Res; 1997 Feb; 57(4):600-3. PubMed ID: 9044833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice.
    Guzman RC; Osborn RC; Swanson SM; Sakthivel R; Hwang SI; Miyamoto S; Nandi S
    Cancer Res; 1992 Oct; 52(20):5732-7. PubMed ID: 1394197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.